We would like to comment on the review article entitled “Manage- ment of status epilepticus in adults. Position paper of the Italian League against Epilepsy” [1]. This article updates the previous article published by the same Italian League against Epilepsy in 2006. In particular, the updating regards some drugs (levetiracetam, lacosamide, midazolam, etc.) that were not available at that time, even if some of these have not yet obtained the specific indication to treat status epilepticus (SE) and their use is considered off-label.
Capovilla, G., Nistico, R., Magrelli, A. (2020). Reply to the article "Management of status epilepticus in adults. Position paper of the Italian League against Epilepsy". EPILEPSY & BEHAVIOR, 107 [10.1016/j.yebeh.2019.106866].
Reply to the article "Management of status epilepticus in adults. Position paper of the Italian League against Epilepsy"
Nistico, Robert;
2020-01-01
Abstract
We would like to comment on the review article entitled “Manage- ment of status epilepticus in adults. Position paper of the Italian League against Epilepsy” [1]. This article updates the previous article published by the same Italian League against Epilepsy in 2006. In particular, the updating regards some drugs (levetiracetam, lacosamide, midazolam, etc.) that were not available at that time, even if some of these have not yet obtained the specific indication to treat status epilepticus (SE) and their use is considered off-label.| File | Dimensione | Formato | |
|---|---|---|---|
|
Reply to the article.pdf
accesso aperto
Descrizione: Reply to the article “Management of status epilepticus in adults. Position paper of the Italian League against Epilepsy”
Licenza:
Copyright dell'editore
Dimensione
218.37 kB
Formato
Adobe PDF
|
218.37 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
